Why Moderna won’t share rights to the COVID-19 vaccine with the government that paid for its development
Moderna recently offered to share ownership of its main patent with the government to resolve the dispute. Whether or not this is enough to satisfy the government’s claims, I believe the dispute points to serious problems in the ways U.S. companies bring drugs and vaccines to market.


















































